IOBTQ · IO Biotech, Inc. · Proposed Sales
$0.00
+0.00 (+0.00%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“Our recurring losses from operations raise substantial doubt about our ability to continue as a going concern. As a result, the financial statements accompanying this Quarterly Report on Form 10-Q include a statement that there is substantial doubt about our ability to continue as a going concern for one year after the date the financial statements were issued, and these financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.”View the 10-Q filed Nov 14, 2025
Market Cap
$14,389
Shares
71.95M
Volume · Oct 6
180
Avg daily vol (3M)
106.37K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-09-11 | Novo Holdings A/S | Stockholder | 1,000,000 | 2024-09-11 | Morgan Stanley & Co. LLC |
| 2024-07-25 | Novo Holdings A/S | 10% Stockholder | 75,000 | 2024-07-25 | Morgan Stanley & Co. LLC |
| 2024-05-10 | Novo Holdings A/S | 10% Stockholder | 658,809 | 2024-05-10 | Morgan Stanley & Co. LLC |
| 2024-02-09 | Novo Holdings A/S | 10% Stockholder | 658,809 | 2024-02-09 | Morgan Stanley & Co. LLC |
Showing 1–4 of 4 filings